Real-World Quantitative Insights into the Treatment Experience of Patients with Cancer in the USA with Subcutaneous Versus Intravenous Drug Delivery
To our knowledge, this study was the first in the USA to survey real-world treatment preferences of patients with cancer experienced with both SC- and IV-delivered care. Findings demonstrated a strong overall preference towards SC delivery, providing valuable insights and highlighting the need to broaden treatment considerations to include patient perspectives.
Authors
- Robert S. Epstein (ORCID: https://orcid.org/0000-0001-5031-302X)
- JoAnn Krenitsky (ORCID: https://orcid.org/0000-0002-9627-6727)
- P. Sarocco
Institutions
- Research Institute for Fragrance Materials (US)
- Halozyme Therapeutics (United States) (US)
- Eisai (United States) (US)
Publication Details
- Journal
- Oncology and Therapy
- Published
- 2025-07-16
- DOI
- https://doi.org/10.1007/s40487-025-00360-4
- Citations
- 1
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 2.63
Funders
- Halozyme